Irinotecan hydrochloride 20 mg/mL

Irinotecan hydrochloride 20 mg/mL is an intravenous injection used in cancer treatment. This medication is designed to target and inhibit the growth of cancer cells, offering a critical option for patients undergoing chemotherapy.

Irinotecan hydrochloride is primarily used in the treatment of various types of cancer. It works by interfering with the enzymes needed for cancer cell replication, thereby slowing or stopping tumor growth. This medication is often prescribed as part of a broader chemotherapy regimen, tailored to the specific needs of the patient. Patients and healthcare providers may explore 'what is Irinotecan hydrochloride used for' to understand its role in cancer therapy.

Common effects of Irinotecan hydrochloride may include nausea, vomiting, diarrhea, and fatigue. Some patients might experience hair loss or changes in blood cell counts. These effects can vary widely among individuals and are typically managed under medical supervision to ensure patient comfort and safety.

Irinotecan hydrochloride should be handled with care, as it is a potent medication. It is essential to follow proper administration protocols to avoid contamination and ensure accurate dosing. Patients should be monitored regularly for any adverse reactions, and any concerns should be discussed with a healthcare provider immediately.

Irinotecan hydrochloride may interact with other medications, including those that affect liver enzymes or blood cell production. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness or safety of this medication.